Search & Summary

customized research when you can't find what you need

Epidiolex (cannabidiol, Greeenwich Bioscienses, Inc.) for Children With Treatment-Resistant Epilepsy Other Than Dravet or Lennox-Gastaut Syndromes

June 5, 2019

This report will focus on the safety and efficacy of Epidiolex (Greenwich Biosciences Inc.) for the management of treatment-resistant epilepsy in children with conditions other than Lennox-Gastaut syndrome (LGS) or Dravet syndrome.